Component
Serum total thyroxine concentration
Serum total thyroxine concentration. Study-specific scope and measurement methods are recorded with each claim.
5 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
At 24 weeks, mean total T4 in iodine-treated children was approximately 40% higher than baseline and hypothyroxinemia prevalence was below 1%; corresponding placebo-group status did not improve significantly.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- false
- evidence_location
- Primary full PDF Methods, Results, Tables 1–2 and Discussion, pp.108–114.
- experimental_model
- Randomized double-blind placebo-controlled 24-week trial in 310 moderately iodine-deficient Albanian children aged 10–12
- exposure
- One supervised oral dose of iodized poppyseed oil containing 400 mg iodine versus sunflower-oil placebo; baseline median urinary iodine 43 micrograms/L, 87% goitrous; iodine 159/placebo 151 randomized.
- limitations
- Baseline groups differed on four psychological tests; analyses adjusted for baseline score, school and sex. Follow-up was 24 weeks, with no proof of lasting IQ or school-performance improvement. Symbol-search test-retest reliability was modest. Dose is a historical depot intervention, not daily intake. The 40% figure is a within-treatment change described in the abstract, not a verified adjusted between-group estimate.
- nutrient_topic
- Iodine research collection; topical membership is not evidence of a direct dietary effect. · Iodine
- organism
- Homo sapiens
- plain_language
- Iodine repletion restored thyroid hormone status in these moderately deficient children.
- primary_references
- [iod-clin-albania2006] Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: a randomized, controlled, double-blind study. (2006). https://pubmed.ncbi.nlm.nih.gov/16400058/ DOI: 10.1093/ajcn/83.1.108
- tissue_or_cell_type
- Thyroid hormones and cognitive/motor testing
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Iodine: thyroid hormone production, deficiency, excess and nutrient interactions (2026-09-17) · lines 1300–1312
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled 24-week trial in 310 moderately iodine-deficient Albanian children aged 10–12 · source_derived_draft · unverified_draft
### iod-clin-albania-thyroxine At 24 weeks, mean total T4 in iodine-treated children was approximately 40% higher than baseline and hypothyroxinemia prevalence was below 1%; corresponding placebo-group status did not improve significantly. Condition category: nutrient_deficiency nutrient_topic: Iodine research collection; topical membership is not evidence of a direct dietary effect. plain_language: Iodine repletion restored thyroid hormone status in these moderately deficient children. organism: Homo sapiens tissue_or_cell_type: Thyroid hormones and cognitive/motor testing experimental_model: Randomized double-blind placebo-controlled 24-week trial in 310 moderately iodine-deficient Albanian children aged 10–12 limitations: Baseline groups differed on four psychological tests; analyses adjusted for baseline score, school and sex. Follow-up was 24 weeks, with no proof of lasting IQ or school-performance improvement. Symbol-search test-retest reliability was modest. Dose is a historical depot intervention, not daily intake. The 40% figure is a within-treatment change described in the abstract, not a verified adjusted between-group estimate. exposure: One supervised oral dose of iodized poppyseed oil containing 400 mg iodine versus sunflower-oil placebo; baseline median urinary iodine 43 micrograms/L, 87% goitrous; iodine 159/placebo 151 randomized. cross_nutrient: false evidence_location: Primary full PDF Methods, Results, Tables 1–2 and Discussion, pp.108–114. [iod-clin-albania2006] Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: a randomized, controlled, double-blind study. (2006). https://pubmed.ncbi.nlm.nih.gov/16400058/ DOI: 10.1093/ajcn/83.1.108
Complete structured claim and evidenceSerum thyroxine was higher with dual-fortified salt than with iodized salt alone (P<0.05), with lower reported hypothyroidism and goiter prevalence (P<0.01).
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- true
- evidence_location
- Primary indexed abstract.
- experimental_model
- Nine-month randomized double-blind controlled trial in 377 goitrous children aged 6–15 with high anemia prevalence
- exposure
- Iodized salt 25 micrograms iodine/g versus dual-fortified salt with the same iodine plus 1 mg iron/g as microencapsulated ferrous sulfate; 40-week measurements.
- limitations
- Clinical intervention and thyroid endpoints do not identify the exact iron-dependent step. Iodized-salt-only participants also improved. Related publications from this cohort are not independent trials. The abstract does not provide the exact between-group thyroxine effect size. The two iron trials have distinct populations and endpoints; their hormone results are not declared a contradiction.
- nutrient_topic
- Iodine research collection; topical membership is not evidence of a direct dietary effect. · Iodine
- organism
- Homo sapiens
- plain_language
- This iron–iodine trial also found a hormone response.
- primary_references
- [iod-clin-zimmer2002] Addition of microencapsulated iron to iodized salt improves the efficacy of iodine in goitrous, iron-deficient children: a randomized, double-blind, controlled trial. (2002). https://pubmed.ncbi.nlm.nih.gov/12457449/ DOI: 10.1530/eje.0.1470747
- tissue_or_cell_type
- Thyroid volume, circulating thyroxine and iron indices
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Iodine: thyroid hormone production, deficiency, excess and nutrient interactions (2026-09-17) · lines 1244–1256
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Nine-month randomized double-blind controlled trial in 377 goitrous children aged 6–15 with high anemia prevalence · source_derived_draft · unverified_draft
### iod-clin-dual-salt-thyroxine Serum thyroxine was higher with dual-fortified salt than with iodized salt alone (P<0.05), with lower reported hypothyroidism and goiter prevalence (P<0.01). Condition category: nutrient_deficiency nutrient_topic: Iodine research collection; topical membership is not evidence of a direct dietary effect. plain_language: This iron–iodine trial also found a hormone response. organism: Homo sapiens tissue_or_cell_type: Thyroid volume, circulating thyroxine and iron indices experimental_model: Nine-month randomized double-blind controlled trial in 377 goitrous children aged 6–15 with high anemia prevalence limitations: Clinical intervention and thyroid endpoints do not identify the exact iron-dependent step. Iodized-salt-only participants also improved. Related publications from this cohort are not independent trials. The abstract does not provide the exact between-group thyroxine effect size. The two iron trials have distinct populations and endpoints; their hormone results are not declared a contradiction. exposure: Iodized salt 25 micrograms iodine/g versus dual-fortified salt with the same iodine plus 1 mg iron/g as microencapsulated ferrous sulfate; 40-week measurements. cross_nutrient: true evidence_location: Primary indexed abstract. [iod-clin-zimmer2002] Addition of microencapsulated iron to iodized salt improves the efficacy of iodine in goitrous, iron-deficient children: a randomized, double-blind, controlled trial. (2002). https://pubmed.ncbi.nlm.nih.gov/12457449/ DOI: 10.1530/eje.0.1470747
Complete structured claim and evidenceThe iron and placebo groups showed no significant difference in serum thyroxine or whole-blood thyrotropin at baseline or during the intervention.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- true
- evidence_location
- Primary indexed abstract.
- experimental_model
- Randomized double-blind placebo-controlled trial in 166 goitrous iron-deficient children aged 5–14 in Côte d’Ivoire
- exposure
- All consumed iodized salt providing 10–30 mg iodine/kg salt at household level; iron group received 60 mg elemental Fe/day, four days/week for 16 weeks; outcomes followed to 20 weeks.
- limitations
- This tests iron treatment on a background of iodine supply. It does not directly measure TPO activity or prove that iron deficiency always prevents iodine response. Specific iron-supplement salt not verified from abstract. The whole-blood thyrotropin assay is identified explicitly; it is not claimed to be the same specimen matrix as serum TSH.
- nutrient_topic
- Iodine research collection; topical membership is not evidence of a direct dietary effect. · Iodine
- organism
- Homo sapiens
- plain_language
- Improved thyroid size did not mean every hormone measurement changed.
- primary_references
- [iod-clin-hess2002] Treatment of iron deficiency in goitrous children improves the efficacy of iodized salt in Côte d'Ivoire. (2002). https://pubmed.ncbi.nlm.nih.gov/11916762/ DOI: 10.1093/ajcn/75.4.743
- tissue_or_cell_type
- Thyroid ultrasound and blood thyroid indices
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Iodine: thyroid hormone production, deficiency, excess and nutrient interactions (2026-09-17) · lines 1216–1228
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized double-blind placebo-controlled trial in 166 goitrous iron-deficient children aged 5–14 in Côte d’Ivoire · source_derived_draft · unverified_draft
### iod-clin-iron-salt-hormone-null The iron and placebo groups showed no significant difference in serum thyroxine or whole-blood thyrotropin at baseline or during the intervention. Condition category: nutrient_deficiency nutrient_topic: Iodine research collection; topical membership is not evidence of a direct dietary effect. plain_language: Improved thyroid size did not mean every hormone measurement changed. organism: Homo sapiens tissue_or_cell_type: Thyroid ultrasound and blood thyroid indices experimental_model: Randomized double-blind placebo-controlled trial in 166 goitrous iron-deficient children aged 5–14 in Côte d’Ivoire limitations: This tests iron treatment on a background of iodine supply. It does not directly measure TPO activity or prove that iron deficiency always prevents iodine response. Specific iron-supplement salt not verified from abstract. The whole-blood thyrotropin assay is identified explicitly; it is not claimed to be the same specimen matrix as serum TSH. exposure: All consumed iodized salt providing 10–30 mg iodine/kg salt at household level; iron group received 60 mg elemental Fe/day, four days/week for 16 weeks; outcomes followed to 20 weeks. cross_nutrient: true evidence_location: Primary indexed abstract. [iod-clin-hess2002] Treatment of iron deficiency in goitrous children improves the efficacy of iodized salt in Côte d'Ivoire. (2002). https://pubmed.ncbi.nlm.nih.gov/11916762/ DOI: 10.1093/ajcn/75.4.743
Complete structured claim and evidenceMean serum total T4 fell from 73.1 ± 45.4 to 48.3 ± 23.7 nmol/L after two months of selenium treatment (P<0.001) in the iodine/selenium-deficient setting.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- true
- evidence_location
- Primary indexed abstract.
- experimental_model
- Placebo-controlled selenium intervention in 52 schoolchildren from a region of severe iodine and selenium deficiency in northern Zaire
- exposure
- Selenium 50 micrograms/day as selenomethionine or placebo for two months; no concurrent iodine-repletion regimen reported in the abstract.
- limitations
- The abstract reports before/after changes in the selenium group; do not mistake these for adjusted between-group estimates. DIO1 restoration was a proposed explanation, not directly measured. Hormone changes do not themselves establish symptomatic deterioration or a universal order for supplement treatment.
- nutrient_topic
- Iodine research collection; topical membership is not evidence of a direct dietary effect. · Iodine
- organism
- Homo sapiens
- plain_language
- Selenium alone lowered circulating T4 in this co-deficient population.
- primary_references
- [iod-clin-contempre1992] Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. (1992). https://pubmed.ncbi.nlm.nih.gov/1424183/ DOI: 10.1111/j.1365-2265.1992.tb02268.x
- tissue_or_cell_type
- Serum thyroid-hormone concentrations
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Iodine: thyroid hormone production, deficiency, excess and nutrient interactions (2026-09-17) · lines 1258–1270
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Placebo-controlled selenium intervention in 52 schoolchildren from a region of severe iodine and selenium deficiency in northern Zaire · source_derived_draft · unverified_draft
### iod-clin-selenium-total-t4 Mean serum total T4 fell from 73.1 ± 45.4 to 48.3 ± 23.7 nmol/L after two months of selenium treatment (P<0.001) in the iodine/selenium-deficient setting. Condition category: nutrient_deficiency nutrient_topic: Iodine research collection; topical membership is not evidence of a direct dietary effect. plain_language: Selenium alone lowered circulating T4 in this co-deficient population. organism: Homo sapiens tissue_or_cell_type: Serum thyroid-hormone concentrations experimental_model: Placebo-controlled selenium intervention in 52 schoolchildren from a region of severe iodine and selenium deficiency in northern Zaire limitations: The abstract reports before/after changes in the selenium group; do not mistake these for adjusted between-group estimates. DIO1 restoration was a proposed explanation, not directly measured. Hormone changes do not themselves establish symptomatic deterioration or a universal order for supplement treatment. exposure: Selenium 50 micrograms/day as selenomethionine or placebo for two months; no concurrent iodine-repletion regimen reported in the abstract. cross_nutrient: true evidence_location: Primary indexed abstract. [iod-clin-contempre1992] Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. (1992). https://pubmed.ncbi.nlm.nih.gov/1424183/ DOI: 10.1111/j.1365-2265.1992.tb02268.x
Complete structured claim and evidence
Where it participates (unsigned role)
Infant thyroid hypofunction classifications were less frequent with indirect maternal supplementation (P=0.023), although infant TSH and T4 concentrations did not differ significantly between groups over time (P=0.597 and 0.184).
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- false
- evidence_location
- Primary PDF Methods, trial profile, Results and Table2, pp.197–209.
- experimental_model
- Double-blind randomized trial in Morocco;241 mother–infant pairs enrolled, 239 randomized after two age exclusions
- exposure
- Term infants ≤ 8 weeks; indirect arm 121 pairs: mother 400 mg iodine as oral iodized poppyseed oil, infant placebo; direct arm 118 pairs: infant about 100 mg iodine from half a 200 mg oil capsule, mother placebo; follow-up 3, 6, 9 months.
- limitations
- Both arms received active iodine somewhere in the pair; there was no wholly untreated arm. Breastfeeding and baseline deficiency contextualize the result; measured iodine status is not a child cognitive outcome. Actual infant study dose was about 100 mg, not the 200 mg guideline discussed elsewhere in the paper. No serious adverse events were reported; this does not establish safety for other infant doses, preparations or settings.
- nutrient_topic
- Iodine research collection; topical membership is not evidence of a direct dietary effect. · Iodine
- organism
- Homo sapiens
- plain_language
- A categorical thyroid outcome improved even though average hormone comparisons were not significant.
- primary_references
- [iod-clin-bouhouch2014] Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double-blind, randomised, placebo-controlled trial. (2014). https://pubmed.ncbi.nlm.nih.gov/24622750/ DOI: 10.1016/s2213-8587(13)70155-4
- tissue_or_cell_type
- Breast milk, infant urine and thyroid function
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Iodine: thyroid hormone production, deficiency, excess and nutrient interactions (2026-09-17) · lines 1566–1578
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind randomized trial in Morocco;241 mother–infant pairs enrolled, 239 randomized after two age exclusions · source_derived_draft · unverified_draft
### iod-clin-lactation-hypofunction Infant thyroid hypofunction classifications were less frequent with indirect maternal supplementation (P=0.023), although infant TSH and T4 concentrations did not differ significantly between groups over time (P=0.597 and 0.184). Condition category: nutrient_deficiency nutrient_topic: Iodine research collection; topical membership is not evidence of a direct dietary effect. plain_language: A categorical thyroid outcome improved even though average hormone comparisons were not significant. organism: Homo sapiens tissue_or_cell_type: Breast milk, infant urine and thyroid function experimental_model: Double-blind randomized trial in Morocco;241 mother–infant pairs enrolled, 239 randomized after two age exclusions limitations: Both arms received active iodine somewhere in the pair; there was no wholly untreated arm. Breastfeeding and baseline deficiency contextualize the result; measured iodine status is not a child cognitive outcome. Actual infant study dose was about 100 mg, not the 200 mg guideline discussed elsewhere in the paper. No serious adverse events were reported; this does not establish safety for other infant doses, preparations or settings. exposure: Term infants ≤ 8 weeks; indirect arm 121 pairs: mother 400 mg iodine as oral iodized poppyseed oil, infant placebo; direct arm 118 pairs: infant about 100 mg iodine from half a 200 mg oil capsule, mother placebo; follow-up 3, 6, 9 months. cross_nutrient: false evidence_location: Primary PDF Methods, trial profile, Results and Table2, pp.197–209. [iod-clin-bouhouch2014] Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double-blind, randomised, placebo-controlled trial. (2014). https://pubmed.ncbi.nlm.nih.gov/24622750/ DOI: 10.1016/s2213-8587(13)70155-4
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.